Cure8 research brief
Why This Matters
IUS can provide rapid, bedside assessment and longitudinal monitoring of IBD activity, which may improve treat-to-target care. Understanding barriers and strategies for implementation matters for patients and clinicians who may gain faster access to monitoring outside of endoscopy or MRI.
Who Should Pay Attention
Gastroenterologists, pediatric gastroenterologists, clinic managers, health system planners, and adult and pediatric patients interested in point-of-care IBD monitoring
Study Snapshot
What To Know
A national virtual roundtable of adult and pediatric gastroenterology experts from multiple provinces discussed three domains: clinical utility of IUS, barriers to implementation (training, infrastructure, reimbursement, workflow, provincial systems), and strategies for expanding access.
The panel concluded IUS could play a growing role within treat-to-target care but that coordinated action on training, quality standards, equipment/infrastructure, and system-level value is needed for equitable, sustainable adoption.
Implementation notes The report is based on expert panel discussion (roundtable) rather than a randomized trial or new primary data. It focuses on practical implementation issues specific to the Canadian provincial health systems and diverse practice settings.
Keep In Mind
This brief is based on the article abstract summarizing an expert roundtable; it reports consensus and implementation priorities rather than new clinical trial data.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.